To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that new treatment for arthritis approved in 2021 will be available on the NHS.
2 July 2021
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing evidence-based guidance to the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. NICE is committed to publishing draft guidance on new medicines at the time of licensing, with final guidance published within three months of licensing wherever possible. The NHS in England is legally required to fund medicines recommended in a NICE appraisal. NICE is currently appraising multiple treatments for arthritis and will publish its guidance in due course.